2014 Q4 Form 10-K Financial Statement

#000114420415008465 Filed on February 12, 2015

View on sec.gov

Income Statement

Concept 2014 Q4 2014 Q3 2014 Q2
Revenue $135.7K $195.0K $66.67K
YoY Change 10.23% 1654.39% 21.2%
Cost Of Revenue $29.20K
YoY Change 92.33%
Gross Profit $37.47K
YoY Change -5.93%
Gross Profit Margin 56.2%
Selling, General & Admin $204.7K
YoY Change 49.39%
% of Gross Profit 546.43%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $0.00 $0.00
YoY Change
% of Gross Profit 0.0%
Operating Expenses $233.9K
YoY Change 53.67%
Operating Profit -$106.9K -$98.44K -$167.3K
YoY Change 149.87% -8.74% 72.05%
Interest Expense $24.81K $35.40K
YoY Change -7.47% 77.52%
% of Operating Profit
Other Income/Expense, Net -$24.81K -$35.40K
YoY Change -115.2%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$142.9K -$123.2K -$202.7K
YoY Change 93.19% -322.81% 72.98%
Net Earnings / Revenue -105.25% -63.19% -303.98%
Basic Earnings Per Share -$0.01 -$0.01 -$0.01
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 21.91M shares 20.44M shares 19.78M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q4 2014 Q3 2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $990.0K $600.0K $70.00K
YoY Change 1314.29% 757.14% 133.33%
Cash & Equivalents $988.7K $596.2K $71.64K
Short-Term Investments
Other Short-Term Assets $0.00 $50.00K $70.00K
YoY Change -100.0% -61.54% 0.0%
Inventory $890.0K $700.0K $570.0K
Prepaid Expenses
Receivables $64.30K $32.85K $98.56K
Other Receivables $30.00K $0.00 $0.00
Total Short-Term Assets $1.975M $1.374M $803.3K
YoY Change 129.65% 76.74% 16.42%
LONG-TERM ASSETS
Property, Plant & Equipment $56.19K $20.24K $21.22K
YoY Change 206.27% 6.28% 6.1%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00
YoY Change
Total Long-Term Assets $57.20K $20.24K $21.22K
YoY Change 211.78% 6.28% 6.1%
TOTAL ASSETS
Total Short-Term Assets $1.975M $1.374M $803.3K
Total Long-Term Assets $57.20K $20.24K $21.22K
Total Assets $2.033M $1.395M $824.5K
YoY Change 131.37% 75.05% 16.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $87.93K $73.27K $72.01K
YoY Change 5.71% -5.19% -19.99%
Accrued Expenses $270.0K $380.0K $360.0K
YoY Change 12.5% 58.33% 56.52%
Deferred Revenue
YoY Change
Short-Term Debt $330.0K $370.0K $330.0K
YoY Change -21.43% 2.78% 106.25%
Long-Term Debt Due $60.00K $70.00K $90.00K
YoY Change -62.5% -46.15% -25.0%
Total Short-Term Liabilities $750.0K $886.7K $859.8K
YoY Change -16.51% 10.23% 8.84%
LONG-TERM LIABILITIES
Long-Term Debt $330.0K $330.0K $340.0K
YoY Change -2.94% -2.94% 0.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $330.0K $330.0K $340.0K
YoY Change -2.94% -2.94% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $750.0K $886.7K $859.8K
Total Long-Term Liabilities $330.0K $330.0K $340.0K
Total Liabilities $1.080M $1.217M $1.203M
YoY Change -12.45% 6.6% 6.49%
SHAREHOLDERS EQUITY
Retained Earnings -$6.426M -$6.303M
YoY Change 6.03%
Common Stock $6.603M $5.924M
YoY Change 15.53%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $960.0K $177.4K -$378.8K
YoY Change
Total Liabilities & Shareholders Equity $2.030M $1.395M $824.5K
YoY Change 131.07% 75.05% 16.13%

Cashflow Statement

Concept 2014 Q4 2014 Q3 2014 Q2
OPERATING ACTIVITIES
Net Income -$142.9K -$123.2K -$202.7K
YoY Change 93.19% -322.81% 72.98%
Depreciation, Depletion And Amortization $0.00 $0.00 $0.00
YoY Change
Cash From Operating Activities -$410.0K -$110.0K -$90.00K
YoY Change 355.56% -31.25% 200.0%
INVESTING ACTIVITIES
Capital Expenditures -$40.00K $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$40.00K $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 840.0K 640.0K 60.00K
YoY Change 950.0% 204.76%
NET CHANGE
Cash From Operating Activities -410.0K -110.0K -90.00K
Cash From Investing Activities -40.00K 0.000 0.000
Cash From Financing Activities 840.0K 640.0K 60.00K
Net Change In Cash 390.0K 530.0K -30.00K
YoY Change -4000.0% 960.0% 0.0%
FREE CASH FLOW
Cash From Operating Activities -$410.0K -$110.0K -$90.00K
Capital Expenditures -$40.00K $0.00 $0.00
Free Cash Flow -$370.0K -$110.0K -$90.00K
YoY Change 311.11% -31.25%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
69613 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
988681 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
90583 USD
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
64298 USD
CY2013Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
4000 USD
CY2014Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
30000 USD
CY2013Q4 ivdn Inventory Net Excluding Inventory On Consignment
InventoryNetExcludingInventoryOnConsignment
614581 USD
CY2013Q4 us-gaap Other Inventory Materials Supplies And Merchandise Under Consignment
OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
42900 USD
CY2014Q4 us-gaap Other Inventory Materials Supplies And Merchandise Under Consignment
OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
0 USD
CY2014Q4 ivdn Inventory Net Excluding Inventory On Consignment
InventoryNetExcludingInventoryOnConsignment
889560 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
898276 USD
CY2013Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
335371 USD
CY2013Q4 us-gaap Liabilities
Liabilities
1233647 USD
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
1935 USD
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
5777606 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6134664 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
-355123 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
878524 USD
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-309609 USD
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-142761 USD
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-230508 USD
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-434070 USD
CY2014Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
50000 shares
CY2014Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
46000 USD
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3419 USD
CY2014Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
115000 shares
CY2014Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1080680 shares
CY2014Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1294320 shares
CY2014Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
632340 USD
CY2014Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
882950 USD
CY2014Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10000 USD
CY2014Q1 us-gaap Share Price
SharePrice
0.20
CY2013Q2 us-gaap Share Price
SharePrice
0.30
CY2014Q2 us-gaap Share Price
SharePrice
0.40
CY2013Q3 us-gaap Share Price
SharePrice
0.40
CY2014Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.20
CY2014Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.60
CY2014Q3 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
12600 USD
CY2014Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
74300 USD
CY2014Q3 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
20800 shares
CY2014Q1 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
371500 shares
CY2013Q2 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
30000 shares
CY2013Q3 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
40000 shares
CY2014Q4 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
20000 shares
CY2013Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
9000 USD
CY2013Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
16000 USD
CY2014Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
16000 USD
CY2014Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.80
CY2013Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
52000 USD
CY2014Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
46000 USD
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19325743 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22438043 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19325743 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22438043 shares
CY2013 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
484299 USD
CY2014 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
771184 USD
CY2013 us-gaap Cost Of Goods Sold
CostOfGoodsSold
206939 USD
CY2014 us-gaap Cost Of Goods Sold
CostOfGoodsSold
433861 USD
CY2013 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
507868 USD
CY2014 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
646932 USD
CY2013 us-gaap Interest Expense
InterestExpense
102253 USD
CY2014 us-gaap Interest Expense
InterestExpense
124461 USD
CY2013 us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
-190000 USD
CY2014 us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
0 USD
CY2013 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
87747 USD
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-124461 USD
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.008
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.021
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
18974811 shares
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20397432 shares
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
-301362 USD
CY2013 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
25000 USD
CY2014 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
87000 USD
CY2014 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
86900 USD
CY2013 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
64000 USD
CY2014 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1571290 USD
CY2013 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
25000 USD
CY2014 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
96400 USD
CY2013 us-gaap Adjustment For Amortization
AdjustmentForAmortization
0 USD
CY2014 us-gaap Adjustment For Amortization
AdjustmentForAmortization
990 USD
CY2013 us-gaap Depreciation
Depreciation
2102 USD
CY2014 us-gaap Depreciation
Depreciation
4000 USD
CY2013 us-gaap Inventory Write Down
InventoryWriteDown
-13000 USD
CY2014 us-gaap Inventory Write Down
InventoryWriteDown
-6000 USD
CY2013 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-7767 USD
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-26285 USD
CY2013 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
0 USD
CY2014 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
26000 USD
CY2013 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
20759 USD
CY2014 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
226079 USD
CY2013 ivdn Increase Decrease In Deposits On Inventory
IncreaseDecreaseInDepositsOnInventory
-13668 USD
CY2014 ivdn Increase Decrease In Deposits On Inventory
IncreaseDecreaseInDepositsOnInventory
-30846 USD
CY2013 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
3295 USD
CY2014 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-4774 USD
CY2013 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
18728 USD
CY2014 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4750 USD
CY2013 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
2543 USD
CY2014 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
83847 USD
CY2013 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
49262 USD
CY2014 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-55634 USD
CY2013 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-250745 USD
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-497891 USD
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
41843 USD
CY2013 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
0 USD
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-41843 USD
CY2013 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
64000 USD
CY2014 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1571290 USD
CY2013 ivdn Payment Of Shareholders Advances
PaymentOfShareholdersAdvances
155100 USD
CY2014 ivdn Payment Of Shareholders Advances
PaymentOfShareholdersAdvances
84000 USD
CY2013 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
305000 USD
CY2014 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
50000 USD
CY2013 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
119933 USD
CY2014 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
158488 USD
CY2013 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
171396 USD
CY2014 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
80000 USD
CY2013 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
265363 USD
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1458802 USD
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
14618 USD
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
919068 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
54995 USD
CY2013 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
0 USD
CY2014 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
86900 USD
CY2013 us-gaap Interest Paid
InterestPaid
52991 USD
CY2014 us-gaap Interest Paid
InterestPaid
173595 USD
CY2013Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
0 USD
CY2014Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1010 USD
CY2014Q4 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
990 USD
CY2013 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
0 USD
CY2014 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-2000 USD
CY2014 dei Document Type
DocumentType
10-K
CY2014 dei Amendment Flag
AmendmentFlag
false
CY2014 dei Document Period End Date
DocumentPeriodEndDate
2014-10-31
CY2014 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2014 dei Entity Registrant Name
EntityRegistrantName
INNOVATIVE DESIGNS INC
CY2014 dei Entity Central Index Key
EntityCentralIndexKey
0001190370
CY2014 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--10-31
CY2014 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2014 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2014 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2014 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2015Q1 dei Entity Public Float
EntityPublicFloat
19149264 USD
CY2014 dei Trading Symbol
TradingSymbol
IVDN
CY2015Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
22721043 shares
CY2014 us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <table style="LINE-HEIGHT: 115%; WIDTH: 100%; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.3pt; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="0"></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.25in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="24"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"> <font style="FONT-SIZE: 10pt">12.</font></div> </td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt" align="justify"><u><font style="FONT-SIZE: 10pt"> LITIGATION</font></u></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 0.25in" align="justify"><font style="FONT-SIZE: 10pt">During 2012, the Company filed a civil complaint in which we asserted that the defendants made deceptive claims in advertising and promotions that were aimed at our Arctic Armor products. The Company was then named as a defendant in a countersuit that asserted libel, slander, and torturous interference. The Company did not respond timely to the summons and complaint in the Minnesota action, and as a result recorded a $190,000 contingent liability as of October 31, 2012.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 0.25in" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 0.25in" align="justify"><font style="FONT-SIZE: 10pt">During 2013, a settlement was reached regarding the open litigation. The Company withdrew the complaint in Pennsylvania, and the defendant withdrew the complaint in Minnesota. The parties have entered a mutual non-disparagement agreement. As a result, the Company has reversed the contingent liability of $190,000 associated with the countersuit as of October 31, 2013.</font></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2012 ivdn Reversal Of Contingent Liability
ReversalOfContingentLiability
190000 USD
CY2013 ivdn Reversal Of Contingent Liability
ReversalOfContingentLiability
190000 USD
CY2014 us-gaap Fiscal Period
FiscalPeriod
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 0.25in" align="justify"><u><font style="FONT-SIZE: 10pt">Fiscal Year End</font></u> <font style="FONT-SIZE: 10pt">- The Company&#8217;s fiscal year ends on October 31. The fiscal years ending October 31, 2014 and 2013 are referred to as 2014 and 2013, respectively, throughout the Company&#8217;s financial statements.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 0.25in" align="justify"><u><font style="FONT-SIZE: 10pt"> Estimates</font></u> <font style="FONT-SIZE: 10pt">- The preparation of financial statements in conformity with accounting principals generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts and disclosures. Actual results may differ from these estimates and assumptions.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 0.25in" align="justify"><u><font style="FONT-SIZE: 10pt">Concentration of Credit Risk</font></u> <font style="FONT-SIZE: 10pt">- The Company maintains its cash and cash equivalents with a financial institution which management believes to be of high credit quality. Their accounts are insured by the Federal Deposit Insurance Corporation (FDIC) up to $250,000 in coverage. The balances in these accounts may, at times, exceed the federally insured limits. The Company has not experienced any losses on the deposits and management believes the Company is not exposed to any significant credit risk related to these accounts. As of October 31, 2014, the Company has $738,681 of uninsured cash balances. There were no uninsured cash balances as of October 31, 2013.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2013Q2 us-gaap Sales Revenue Net
SalesRevenueNet
55010 USD
CY2014Q2 us-gaap Sales Revenue Net
SalesRevenueNet
66670 USD
CY2013Q3 us-gaap Sales Revenue Net
SalesRevenueNet
11117 USD
CY2014Q3 us-gaap Sales Revenue Net
SalesRevenueNet
195035 USD
CY2013Q4 us-gaap Sales Revenue Net
SalesRevenueNet
123126 USD
CY2014Q4 us-gaap Sales Revenue Net
SalesRevenueNet
135727 USD
CY2013Q1 us-gaap Sales Revenue Net
SalesRevenueNet
295046 USD
CY2013 us-gaap Sales Revenue Net
SalesRevenueNet
484299 USD
CY2014Q1 us-gaap Sales Revenue Net
SalesRevenueNet
373752 USD
CY2014 us-gaap Sales Revenue Net
SalesRevenueNet
771184 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-97217 USD
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-167260 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-107870 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-98437 USD
CY2013Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-42772 USD
CY2014Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-106876 USD
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
17351 USD
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
62964 USD
CY2013 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
50400 USD
CY2014 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
50650 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-117160 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-202663 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
55316 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-123249 USD
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
-73945 USD
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
-142852 USD
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-6972 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
34694 USD
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18964732 shares
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19776232 shares
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18980091 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20444578 shares
CY2013Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19023134 shares
CY2014Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21908380 shares
CY2013Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18935743 shares
CY2013 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18974811 shares
CY2014Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19440281 shares
CY2014 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20397432 shares
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.006
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.010
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.003
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.006
CY2013Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.004
CY2014Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.007
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.000
CY2013 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.008
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.002
CY2014 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.021
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
948500 USD
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
986000 USD
CY2013Q4 ivdn Deferred Tax Liability Depreciation
DeferredTaxLiabilityDepreciation
200 USD
CY2014Q4 ivdn Deferred Tax Liability Depreciation
DeferredTaxLiabilityDepreciation
0 USD
CY2013Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
948300 USD
CY2014Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
986000 USD
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
948300 USD
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
986000 USD
CY2013Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2014Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2014 ivdn Licensing And Manufacturing Description
LicensingAndManufacturingDescription
The Company received an exclusive forty (40) year worldwide license, except for Korea and Japan, with an initial term of ten (10) years and an option to renew the License for up to three (3) successive ten (10) year terms. Additionally, the Company was granted the exclusive rights to any current or future inventions, improvements, discoveries, patent applications and letters of patent
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.34 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.34 pure
CY2013 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2014Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
2900000 USD
CY2014 us-gaap Tax Credit Carryforward Expiration Date
TaxCreditCarryforwardExpirationDate
2025-10-31
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
52726 USD
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
94569 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
34380 USD
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
38380 USD
CY2013Q4 us-gaap Notes Payable
NotesPayable
490424 USD
CY2014Q4 us-gaap Notes Payable
NotesPayable
386936 USD
CY2013Q4 us-gaap Long Term Debt
LongTermDebt
906924 USD
CY2014Q4 us-gaap Long Term Debt
LongTermDebt
716936 USD
CY2014Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
389407 USD
CY2014Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
12481 USD
CY2014Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
12874 USD
CY2014Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
13252 USD
CY2014Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
13642 USD
CY2014Q4 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
275280 USD
CY2013 us-gaap Shipping Handling And Transportation Costs
ShippingHandlingAndTransportationCosts
29827 USD
CY2014 us-gaap Shipping Handling And Transportation Costs
ShippingHandlingAndTransportationCosts
29568 USD
CY2013Q4 us-gaap Capital Lease Obligations
CapitalLeaseObligations
0 USD
CY2014Q4 us-gaap Capital Lease Obligations
CapitalLeaseObligations
41843 USD
CY2005Q3 us-gaap Notes Payable
NotesPayable
280100 USD
CY2012Q3 us-gaap Debt Instrument Description
DebtInstrumentDescription
120 days
CY2013Q4 us-gaap Advances To Affiliate
AdvancesToAffiliate
31000 USD
CY2005Q3 us-gaap Debt Instrument Periodic Payment
DebtInstrumentPeriodicPayment
1186 USD
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21638043 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21638043 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2014Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 USD
CY2014Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
738681 USD

Files In Submission

Name View Source Status
0001144204-15-008465-index-headers.html Edgar Link pending
0001144204-15-008465-index.html Edgar Link pending
0001144204-15-008465.txt Edgar Link pending
0001144204-15-008465-xbrl.zip Edgar Link pending
ex31tsig.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ivdn-20141031.xml Edgar Link completed
ivdn-20141031.xsd Edgar Link pending
ivdn-20141031_cal.xml Edgar Link unprocessable
ivdn-20141031_def.xml Edgar Link unprocessable
ivdn-20141031_lab.xml Edgar Link unprocessable
ivdn-20141031_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v400742_10k.htm Edgar Link pending
v400742_ex3-1.htm Edgar Link pending
v400742_ex31-1.htm Edgar Link pending
v400742_ex31-2.htm Edgar Link pending
v400742_ex32-1.htm Edgar Link pending
v400742_ex32-2.htm Edgar Link pending